Imatinib Unknown Status Phase N/A Trials for Chronic Myeloid Leukemia (CML)

IndicationsStatusPurposePhase
Unknown StatusNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01860456TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study